Table 2.
Baseline Participants’ Characteristics Stratified by Intervention Assignment.
| SGM (n = 35) | Control (n = 32) | |
|---|---|---|
| Age (years), mean (SD) | 52 (12) | 53 (11) |
| Female, n (%) | 13 (37%) | 14 (43%) |
| Body mass index (kg/m2), mean (SD) | 27.5 (3) | 27 (3.7) |
| Less than high school education, n (%) | 23 (65%) | 22 (69%) |
| Years treated diabetes, mean (SD) | 11 (6) | 11 (7) |
| A1c, mean (SD) | 9.5 (1.6) | 9.4 (1.3) |
| Complications, n (%) | ||
| Retinopathy | 6 (17%) | 5 (17%) |
| Neuropathy | 6 (17%) | 5 (17%) |
| Nephropathy | 6 (17%) | 5 (17%) |
| Treatment, n (%) | ||
| 0-1 medications | 6 (17%) | 6 (19%) |
| 2-4 oral medications | 17 (49%) | 15 (47%) |
| Insulin | 12 (34%) | 11(34%) |